drugset / Trial / NCT03338244
Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
Phase 4
Completed
66228 enrolled
University of California, San Francisco
Bill and Melinda Gates Foundation · collabThe Carter Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
MORDOR was a cluster-randomized placebo controlled trial that assessed the efficacy of mass azithromycin distributions for the prevention of childhood mortality. All communities were subsequently treated with mass azithromycin for one year. The present trial re-randomized communities to azithromycin or placebo for the fourth and fifth year of the study.
Timeline
- Start
- 2017-10-20
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | — | Oral |
Indications
No indication recorded.